$4.47 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 122 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NUVALENT INC | $268,647,000 | -27.0% | 19,341,024 | 0.0% | 6.01% | -22.2% | ||
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $141,877,000 | +9.0% | 157,390,000 | 0.0% | 3.17% | +16.2% | ||
| ENVISTA HOLDINGS CORPORATIONnote 2.375% 6/0 | $123,924,000 | +6.3% | 52,500,000 | 0.0% | 2.77% | +13.3% | ||
| PACIRA BIOSCIENCES INCnote 0.750% 8/0 | $100,908,000 | +11.5% | 81,600,000 | 0.0% | 2.26% | +18.9% | ||
| NUVASIVE INCnote 1.000% 6/0 | $96,433,000 | -0.2% | 96,966,000 | 0.0% | 2.16% | +6.4% | ||
| INSULET CORPnote 0.375% 9/0 | $76,232,000 | -0.2% | 57,581,000 | 0.0% | 1.70% | +6.4% | ||
| MIRM | MIRUM PHARMACEUTICALS INC | $72,290,000 | +38.1% | 3,282,912 | 0.0% | 1.62% | +47.2% | |
| NEVRO CORPnote 2.750% 4/0 | $65,368,000 | -4.1% | 61,000,000 | 0.0% | 1.46% | +2.2% | ||
| ORGO | ORGANOGENESIS HLDGS INC | $64,441,000 | -17.5% | 8,456,876 | 0.0% | 1.44% | -12.1% | |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $52,992,000 | -2.6% | 57,791,000 | 0.0% | 1.18% | +3.9% | ||
| DCPH | DECIPHERA PHARMACEUTICALS IN | $51,731,000 | -5.1% | 5,580,456 | 0.0% | 1.16% | +1.1% | |
| BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $47,402,000 | -19.5% | 80,000,000 | 0.0% | 1.06% | -14.2% | ||
| MOH | MOLINA HEALTHCARE INC | $45,031,000 | +4.9% | 134,989 | 0.0% | 1.01% | +11.8% | |
| AERI | AERIE PHARMACEUTICALS INC | $42,725,000 | +29.6% | 4,695,020 | 0.0% | 0.96% | +38.2% | |
| ATEC | ALPHATEC HLDGS INC | $41,341,000 | +0.6% | 3,594,829 | 0.0% | 0.92% | +7.2% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $38,151,000 | -36.5% | 3,933,137 | 0.0% | 0.85% | -32.4% | |
| THE ONCOLOGY INSTITUTE INC | $32,137,000 | 0.0% | 3,296,107 | 0.0% | 0.72% | +6.5% | ||
| NOVAVAX INCnote 3.750% 2/0 | $26,777,000 | -22.2% | 25,000,000 | 0.0% | 0.60% | -17.0% | ||
| LRMR | LARIMAR THERAPEUTICS INC | $23,613,000 | -62.5% | 5,830,249 | 0.0% | 0.53% | -60.0% | |
| RVMD | REVOLUTION MEDICINES INC | $22,744,000 | +1.4% | 891,587 | 0.0% | 0.51% | +7.9% | |
| XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1 | $21,095,000 | -2.2% | 18,000,000 | 0.0% | 0.47% | +4.2% | ||
| NUVB | NUVATION BIO INC | $18,816,000 | -38.1% | 3,577,233 | 0.0% | 0.42% | -34.0% | |
| OM | OUTSET MED INC | $18,188,000 | -1.5% | 400,622 | 0.0% | 0.41% | +5.2% | |
| HEALTH CATALYST INCnote 2.500% 4/1 | $17,171,000 | -21.2% | 15,000,000 | 0.0% | 0.38% | -16.0% | ||
| DA32 LIFE SCNCE TEC ACQSTN C | $15,544,000 | -1.0% | 1,600,000 | 0.0% | 0.35% | +5.8% | ||
| PROF | PROFOUND MED CORP | $15,424,000 | -19.9% | 1,713,797 | 0.0% | 0.34% | -14.6% | |
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $15,076,000 | -1.6% | 14,527,000 | 0.0% | 0.34% | +5.0% | ||
| ALEC | ALECTOR INC | $15,036,000 | -31.0% | 1,055,192 | 0.0% | 0.34% | -26.5% | |
| COGT | COGENT BIOSCIENCES INC | $11,991,000 | -12.7% | 1,601,000 | 0.0% | 0.27% | -6.9% | |
| MRUS | MERUS N V | $11,554,000 | -16.9% | 437,000 | 0.0% | 0.26% | -11.3% | |
| KNTE | KINNATE BIOPHARMA INC | $11,097,000 | -36.5% | 985,568 | 0.0% | 0.25% | -32.2% | |
| APEN | APOLLO ENDOSURGERY INC | $10,588,000 | -28.2% | 1,750,000 | 0.0% | 0.24% | -23.3% | |
| SRSA | SARISSA CAPITAL ACQUISITN COcl a | $9,900,000 | +1.1% | 999,999 | 0.0% | 0.22% | +7.8% | |
| EUCR | EUCRATES BIOMEDICAL ACQU COR | $9,840,000 | +0.8% | 999,999 | 0.0% | 0.22% | +7.3% | |
| SNRH | SENIOR CONNECT ACQUISITN COR | $9,820,000 | +0.8% | 1,000,000 | 0.0% | 0.22% | +7.8% | |
| REVH | REVOLUTION HEALTHCAR AQ CORP | $9,810,000 | +0.7% | 1,000,000 | 0.0% | 0.22% | +7.4% | |
| MTAC | MEDTECH ACQUISITION CORP | $9,800,000 | -0.8% | 999,999 | 0.0% | 0.22% | +5.8% | |
| INZY | INOZYME PHARMA INC | $9,590,000 | -40.0% | 2,344,786 | 0.0% | 0.21% | -36.1% | |
| NYXOAH S A | $8,714,000 | -16.8% | 455,262 | 0.0% | 0.20% | -11.4% | ||
| TMPM | TURMERIC ACQUISITION CORPcl a | $7,388,000 | +0.3% | 750,000 | 0.0% | 0.16% | +7.1% | |
| IGNY | IGNYTE ACQUISITION CORP | $7,134,000 | +1.0% | 725,000 | 0.0% | 0.16% | +7.4% | |
| TERN | TERNS PHARMACEUTICALS INC | $6,967,000 | -58.0% | 2,345,959 | 0.0% | 0.16% | -55.2% | |
| QSI | QUANTUM SI INC | $6,552,000 | -40.5% | 1,400,000 | 0.0% | 0.15% | -36.8% | |
| GRAY | GRAYBUG VISION INC | $6,497,000 | -32.8% | 5,281,713 | 0.0% | 0.14% | -28.6% | |
| BENEFITFOCUS INCnote 1.250%12/1 | $6,311,000 | +1.3% | 6,500,000 | 0.0% | 0.14% | +7.6% | ||
| ONCR | ONCORUS INC | $5,605,000 | -66.2% | 3,148,977 | 0.0% | 0.12% | -64.1% | |
| VINC | VINCERX PHARMA INC | $5,517,000 | -60.7% | 1,379,310 | 0.0% | 0.12% | -58.3% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $4,948,000 | -46.1% | 6,949,416 | 0.0% | 0.11% | -42.2% | |
| OHPA | ORION ACQUISITION CORP | $4,885,000 | -0.1% | 500,000 | 0.0% | 0.11% | +5.8% | |
| HOWL | WEREWOLF THERAPEUTICS INC | $4,216,000 | -63.1% | 958,125 | 0.0% | 0.09% | -60.7% | |
| AFIB | ACUTUS MED INC | $3,681,000 | -59.2% | 2,648,386 | 0.0% | 0.08% | -56.6% | |
| DCTH | DELCATH SYS INC | $3,200,000 | -17.4% | 500,000 | 0.0% | 0.07% | -11.1% | |
| GKOS | GLAUKOS CORPcall | $2,613,000 | +30.1% | 45,200 | 0.0% | 0.06% | +38.1% | |
| NEOGENOMICS INCnote 0.250% 1/1 | $1,666,000 | -21.9% | 2,500,000 | 0.0% | 0.04% | -17.8% | ||
| ANNX | ANNEXON INC | $1,594,000 | -76.2% | 583,913 | 0.0% | 0.04% | -74.5% | |
| THE ONCOLOGY INSTITUTE INC*w exp 11/15/202 | $1,438,000 | +66.6% | 1,250,000 | 0.0% | 0.03% | +77.8% | ||
| BCAB | BIOATLA INC | $1,445,000 | -74.5% | 289,002 | 0.0% | 0.03% | -73.1% | |
| CMAXW | CAREMAX INC*w exp 06/08/202 | $1,277,000 | +35.7% | 672,000 | 0.0% | 0.03% | +45.0% | |
| MDVL | MEDAVAIL HOLDINGS INC | $1,110,000 | -30.6% | 1,142,552 | 0.0% | 0.02% | -26.5% | |
| CABA | CABALETTA BIO INC | $942,000 | -46.5% | 464,252 | 0.0% | 0.02% | -43.2% | |
| ROIVANT SCIENCES LTD*w exp 09/30/202 | $880,000 | -57.0% | 1,000,000 | 0.0% | 0.02% | -53.5% | ||
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $748,000 | -19.7% | 733,333 | 0.0% | 0.02% | -15.0% | |
| QSIAW | QUANTUM SI INC*w exp 06/10/202 | $383,000 | -36.2% | 333,333 | 0.0% | 0.01% | -30.8% | |
| SOMALOGIC INC*w exp 08/31/202 | $257,000 | -35.9% | 120,000 | 0.0% | 0.01% | -25.0% | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $135,000 | -57.1% | 166,666 | 0.0% | 0.00% | -57.1% | |
| IGNYW | IGNYTE ACQUISITION CORP*w exp 01/05/202 | $132,000 | -52.7% | 362,500 | 0.0% | 0.00% | -50.0% | |
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $82,000 | -51.8% | 250,000 | 0.0% | 0.00% | -50.0% | |
| REVHW | REVOLUTION HEALTHCAR AQ CORP*w exp 12/31/202 | $90,000 | -40.0% | 200,000 | 0.0% | 0.00% | -33.3% | |
| MTACW | MEDTECH ACQUISITION CORP*w exp 12/22/202 | $85,000 | -51.1% | 333,333 | 0.0% | 0.00% | -50.0% | |
| SNRHW | SENIOR CONNECT ACQUISITN COR*w exp 12/31/202 | $90,000 | -65.8% | 500,000 | 0.0% | 0.00% | -66.7% | |
| OHPAW | ORION ACQUISITION CORP*w exp 02/19/202 | $39,000 | -51.9% | 125,000 | 0.0% | 0.00% | -50.0% | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $62,000 | -67.9% | 333,333 | 0.0% | 0.00% | -75.0% | |
| SURROZEN INC*w exp 08/01/203 | $42,000 | -78.1% | 166,666 | 0.0% | 0.00% | -75.0% | ||
| WINT | WINDTREE THERAPEUTICS INC | $23,000 | -28.1% | 20,148 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.